Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$0.10 and traded as high as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 16,820 shares traded.
Resverlogix Price Performance
The stock’s 50 day simple moving average is C$0.10 and its 200-day simple moving average is C$0.10. The firm has a market cap of C$32.71 million, a price-to-earnings ratio of -2.38 and a beta of 0.35. The company has a debt-to-equity ratio of -82.47, a quick ratio of 0.04 and a current ratio of 0.04.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Further Reading
- Five stocks we like better than Resverlogix
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
